Idera Presents Preclinical Data at ASCO on Agonists to Toll-like Receptor 9 in Combination with Chemotherapeutic and Targeted Therapies in Lung Cancer Models
Idera Presents Preclinical Data at ASCO on Agonists to Toll-like Receptor 9 in Combination with Chemotherapeutic and Targeted Therapies in Lung Cancer Models
Jun 05, 2006
Click here to access PDF press release.